Management of the axilla.

Management of the axilla.
Hematol Oncol Clin North Am. 2013 Aug;27(4):687-702
Authors: Amersi F, Giuliano AE
Abstract
The development and wide acceptance of sentinel lymph node biopsy (SLNB) has profoundly affected the management of breast cancer. SLNB has spared the additional morbidity of axillary lymph node dissection (ALND) without compromising diagnostic accuracy and prognostic information in patients with clinically node-negative early-stage breast cancer. It has become an invaluable tool to clinicians to guide decisions regarding adjuvant treatment. The management of breast cancer continues to advance to more minimally invasive approaches, and the role of ALND is likely to become less important in the future.
PMID: 23915739 [PubMed - in process]

Source: Clinical Breast Cancer - August 1, 2013 Category: Cancer & Oncology Authors: Amersi F, Giuliano AE Tags: Hematol Oncol Clin North Am Source Type: research